File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3748/wjg.v16.i4.403
- Scopus: eid_2-s2.0-76149116164
- PMID: 20101763
- WOS: WOS:000274150400001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Probiotics and gut health: A special focus on liver diseases
Title | Probiotics and gut health: A special focus on liver diseases |
---|---|
Authors | |
Keywords | Bacterial overgrowth Barrier function Endotoxin Ethanol Gut Liver Probiotics Translocation |
Issue Date | 2010 |
Publisher | Baishideng Publishing Group. The Journal's web site is located at http://www.wjgnet.com/1007-9327/index.htm |
Citation | World Journal Of Gastroenterology, 2010, v. 16 n. 4, p. 403-410 How to Cite? |
Abstract | Probiotic bacteria have well-established beneficial effects in the management of diarrhoeal diseases. Newer evidence suggests that probiotics have the potential to reduce the risk of developing inflammatory bowel diseases and intestinal bacterial overgrowth after gut surgery. In liver health, the main benefits of probiotics might occur through preventing the production and/or uptake of lipopolysaccharides in the gut, and therefore reducing levels of low-grade inflammation. Specific immune stimulation by probiotics through processes involving dendritic cells might also be beneficial to the host immunological status and help prevent pathogen translocation. Hepatic fat metabolism also seems to be influenced by the presence of commensal bacteria, and potentially by probiotics; although the mechanisms by which probiotic might act on the liver are still unclear. However, this might be of major importance in the future because low-grade inflammation, hepatic fat infiltration, and hepatitis might become more prevalent as a result of high fat intake and the increased prevalence of obesity. © 2010 Baishideng. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/123976 |
ISSN | 2023 Impact Factor: 4.3 2023 SCImago Journal Rankings: 1.063 |
PubMed Central ID | |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gratz, SW | en_HK |
dc.contributor.author | Mykkanen, H | en_HK |
dc.contributor.author | ElNezami, HS | en_HK |
dc.date.accessioned | 2010-10-14T03:15:12Z | - |
dc.date.available | 2010-10-14T03:15:12Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | World Journal Of Gastroenterology, 2010, v. 16 n. 4, p. 403-410 | en_HK |
dc.identifier.issn | 1007-9327 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/123976 | - |
dc.description.abstract | Probiotic bacteria have well-established beneficial effects in the management of diarrhoeal diseases. Newer evidence suggests that probiotics have the potential to reduce the risk of developing inflammatory bowel diseases and intestinal bacterial overgrowth after gut surgery. In liver health, the main benefits of probiotics might occur through preventing the production and/or uptake of lipopolysaccharides in the gut, and therefore reducing levels of low-grade inflammation. Specific immune stimulation by probiotics through processes involving dendritic cells might also be beneficial to the host immunological status and help prevent pathogen translocation. Hepatic fat metabolism also seems to be influenced by the presence of commensal bacteria, and potentially by probiotics; although the mechanisms by which probiotic might act on the liver are still unclear. However, this might be of major importance in the future because low-grade inflammation, hepatic fat infiltration, and hepatitis might become more prevalent as a result of high fat intake and the increased prevalence of obesity. © 2010 Baishideng. All rights reserved. | en_HK |
dc.language | eng | - |
dc.publisher | Baishideng Publishing Group. The Journal's web site is located at http://www.wjgnet.com/1007-9327/index.htm | en_HK |
dc.relation.ispartof | World Journal of Gastroenterology | en_HK |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Bacterial overgrowth | en_HK |
dc.subject | Barrier function | en_HK |
dc.subject | Endotoxin | en_HK |
dc.subject | Ethanol | en_HK |
dc.subject | Gut | en_HK |
dc.subject | Liver | en_HK |
dc.subject | Probiotics | en_HK |
dc.subject | Translocation | en_HK |
dc.subject.mesh | Gastrointestinal Diseases - drug therapy | - |
dc.subject.mesh | Humans | - |
dc.subject.mesh | Intestinal Mucosa - drug effects | - |
dc.subject.mesh | Liver Diseases - drug therapy | - |
dc.subject.mesh | Probiotics - pharmacology - therapeutic use | - |
dc.title | Probiotics and gut health: A special focus on liver diseases | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1007-9327&volume=16&issue=4&spage=403&epage=410&date=2010&atitle=Probiotics+and+gut+health:+a+special+focus+on+liver+disease | - |
dc.identifier.email | ElNezami, HS: elnezami@hkucc.hku.hk | en_HK |
dc.identifier.authority | ElNezami, HS=rp00694 | en_HK |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3748/wjg.v16.i4.403 | en_HK |
dc.identifier.pmid | 20101763 | - |
dc.identifier.pmcid | PMC2811790 | - |
dc.identifier.scopus | eid_2-s2.0-76149116164 | en_HK |
dc.identifier.hkuros | 172284 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-76149116164&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 16 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 403 | en_HK |
dc.identifier.epage | 410 | en_HK |
dc.identifier.isi | WOS:000274150400001 | - |
dc.publisher.place | China | en_HK |
dc.identifier.scopusauthorid | Gratz, SW=9242677500 | en_HK |
dc.identifier.scopusauthorid | Mykkanen, H=7003915985 | en_HK |
dc.identifier.scopusauthorid | ElNezami, HS=6603690577 | en_HK |
dc.identifier.issnl | 1007-9327 | - |